These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 17006765

  • 1. Pro-angiogenic cytokines and their role in tumor angiogenesis.
    Neufeld G, Kessler O.
    Cancer Metastasis Rev; 2006 Sep; 25(3):373-85. PubMed ID: 17006765
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biology of angiogenesis in tumors of the gastrointestinal tract.
    Reinmuth N, Parikh AA, Ahmad SA, Liu W, Stoeltzing O, Fan F, Takeda A, Akagi M, Ellis LM.
    Microsc Res Tech; 2003 Feb 01; 60(2):199-207. PubMed ID: 12539174
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis.
    Affara NI, Robertson FM.
    In Vivo; 2004 Feb 01; 18(5):525-42. PubMed ID: 15523889
    [Abstract] [Full Text] [Related]

  • 6. Targeting angiogenesis with antibodies for the treatment of cancer.
    Andreasson P, Carlsson R.
    IDrugs; 2005 Sep 01; 8(9):730-3. PubMed ID: 16118694
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor (VEGF) signaling in tumor progression.
    Roskoski R.
    Crit Rev Oncol Hematol; 2007 Jun 01; 62(3):179-213. PubMed ID: 17324579
    [Abstract] [Full Text] [Related]

  • 8. Tumorangiogenesis: a network of cytokines.
    Hotfilder M, Nowak-Göttl U, Wolff JE.
    Klin Padiatr; 1997 Jun 01; 209(4):265-70. PubMed ID: 9293460
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
    Laakkonen P, Waltari M, Holopainen T, Takahashi T, Pytowski B, Steiner P, Hicklin D, Persaud K, Tonra JR, Witte L, Alitalo K.
    Cancer Res; 2007 Jan 15; 67(2):593-9. PubMed ID: 17234768
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumor angiogenesis--a potential target in cancer chemoprevention.
    Bhat TA, Singh RP.
    Food Chem Toxicol; 2008 Apr 15; 46(4):1334-45. PubMed ID: 17919802
    [Abstract] [Full Text] [Related]

  • 13. [Angiogenesis and metastasis of carcinoma].
    Chen L, Shibasaki F.
    Clin Calcium; 2006 Apr 15; 16(4):613- 19. PubMed ID: 16582512
    [Abstract] [Full Text] [Related]

  • 14. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F, Ferrara N.
    Drug Resist Updat; 2008 Dec 15; 11(6):219-30. PubMed ID: 18948057
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
    Yang AD, Bauer TW, Camp ER, Somcio R, Liu W, Fan F, Ellis LM.
    Cancer; 2005 Apr 15; 103(8):1561-70. PubMed ID: 15754332
    [Abstract] [Full Text] [Related]

  • 17. Anti-angiogenic therapy against gastrointestinal tract cancers.
    Iwasaki J, Nihira S.
    Jpn J Clin Oncol; 2009 Sep 15; 39(9):543-51. PubMed ID: 19531544
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T, Nakahama K, Asakawa Y, Maemura T, Tanaka M, Takeda S, Morita M, Morita I.
    Gynecol Endocrinol; 2009 Feb 15; 25(2):104-9. PubMed ID: 19253105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.